That ignores if any structural damage has been done, because ideally when a company stumbles it is temporary and not the company's fault. Despite A2 selling an essential product that has always been available to consumers throughout the pandemic, it is interesting that the business is not growing in unimpacted segments. For instance, the China label sales have stagnated for the last 3 halves. Anchoring to previous EPS is probably a mistake as that assumes a full recovery of Diaguo etc.
That ignores if any structural damage has been done, because...
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.89 |
Change
0.065(0.95%) |
Mkt cap ! $5.006B | |||
| Open | High | Low | Value | Volume |
| $6.87 | $6.93 | $6.83 | $6.149M | 892.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 8029 | $6.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.89 | 9523 | 23 |
View Market Depth
| Last trade - 15.23pm 11/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |